William Spencer to Adult
This is a "connection" page, showing publications William Spencer has written about Adult.
Connection Strength
0.208
-
Determination of the best early warning scores to predict clinical outcomes of patients in the emergency department. Emerg Med J. 2019 Dec; 36(12):716-721.
Score: 0.048
-
Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy the Baylor and Medical University of South Carolina experience 1996 to 2007. JACC Cardiovasc Interv. 2008 Oct; 1(5):561-70.
Score: 0.022
-
Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: short-term results in 50 consecutive procedures. Clin Cardiol. 2003 Jun; 26(6):275-9.
Score: 0.016
-
Percutaneous transluminal septal reduction for hypertrophic obstructive cardiomyopathy: report from an international pilot study. J Med Syst. 2002 Aug; 26(4):293-300.
Score: 0.015
-
Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up. J Am Coll Cardiol. 2000 Sep; 36(3):852-5.
Score: 0.013
-
Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1999 Oct; 34(4):1123-8.
Score: 0.012
-
Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation. 1999 Jan 26; 99(3):344-7.
Score: 0.011
-
Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation. 1998 Oct 27; 98(17):1750-5.
Score: 0.011
-
Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1998 Jul; 32(1):225-9.
Score: 0.011
-
Subclavian venogram as a guide to lead implantation. Pacing Clin Electrophysiol. 1998 Mar; 21(3):499-502.
Score: 0.011
-
Comparison of ventricular function in atrial rate adaptive versus dual chamber rate adaptive pacing during exercise. Pacing Clin Electrophysiol. 1994 Feb; 17(2):179-85.
Score: 0.008
-
Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008 Nov 18; 52(21):1718-23.
Score: 0.006
-
Effectiveness of percutaneous intervention for patients with obstructive hypertrophic cardiomyopathy and coronary artery disease. Am J Cardiol. 2005 Aug 15; 96(4):580-1.
Score: 0.005
-
Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy. Circulation. 2004 Feb 24; 109(7):824-7.
Score: 0.004
-
Gated SPECT in patients with hypertrophic obstructive cardiomyopathy undergoing transcoronary ethanol septal ablation. J Nucl Cardiol. 2002 Nov-Dec; 9(6):594-600.
Score: 0.004
-
Decreased expression of tumor necrosis factor-alpha and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy. Circulation. 2001 Apr 10; 103(14):1844-50.
Score: 0.003
-
Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2001 Jan; 37(1):208-14.
Score: 0.003
-
Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation. 1999 Jan 19; 99(2):254-61.
Score: 0.003
-
Apex cardiogram in patients with prolapsing mitral valve. Am J Cardiol. 1973 Sep 07; 32(3):276-82.
Score: 0.002
-
Results of coronary bypass more than 5 years after operation in 434 patients. Clinical, treadmill exercise and angiographic correlations. Am J Cardiol. 1977 Nov; 40(5):665-72.
Score: 0.001